doi: 10.1111/j.1476-5381.1971.tb07199.x.
Pharmacokinetics of cyclophosphamide in man
- PMID: 5157730
- PMCID: PMC1665783
- DOI: 10.1111/j.1476-5381.1971.tb07199.x
Item in Clipboard
Pharmacokinetics of cyclophosphamide in man
Br J Pharmacol.
1971 Nov.
Abstract
1. The pharmacokinetics of cyclophosphamide were investigated in cancer patients. The data can be characterized by a two-compartment open model. The half life of the elimination phase of the drug ranged between 3 and 11 hours.2. Extensive tubular reabsorption of the drug resulted in the excretion of only a small percentage of the administered dose. The mean renal clearance was 10.7 ml/minute.3. The calculated fraction of the dose of drug which was metabolized averaged 88%.
Similar articles
-
Phenobarbital effects on cyclophosphamide pharmacokinetics in man.Cancer Res. 1972 Dec;32(12):2761-4. Cancer Res. 1972. PMID: 4678592 No abstract available.
-
Simultaneous tubular excretion and reabsorption of pindolol in man.Eur J Clin Pharmacol. 1981;21(1):65-72. doi: 10.1007/BF00609590. Eur J Clin Pharmacol. 1981. PMID: 7333348
-
The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.Acta Pharmacol Toxicol (Copenh). 1974 Aug;35(2):98-106. doi: 10.1111/j.1600-0773.1974.tb00729.x. Acta Pharmacol Toxicol (Copenh). 1974. PMID: 4479366 No abstract available.
-
The comparative pharmacology of cyclophosphamide and ifosfamide.Semin Oncol. 1982 Dec;9(4 Suppl 1):2-7. Semin Oncol. 1982. PMID: 6761865 Review. No abstract available.
-
Prediction of human pharmacokinetics - renal metabolic and excretion clearance.J Pharm Pharmacol. 2007 Nov;59(11):1463-71. doi: 10.1211/jpp.59.11.0002. J Pharm Pharmacol. 2007. PMID: 17976256 Review.
Cited by
-
Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography.Cancer Chemother Pharmacol. 1978;1(4):229-31. doi: 10.1007/BF00257155. Cancer Chemother Pharmacol. 1978. PMID: 750109
-
Phase I clinical and pharmacokinetic study of cyclophosphamide administered by five-day continuous intravenous infusion.Cancer Chemother Pharmacol. 1986;18(1):33-8. doi: 10.1007/BF00253060. Cancer Chemother Pharmacol. 1986. PMID: 3757157
-
Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patients.Eur J Drug Metab Pharmacokinet. 1979;4(2):83-5. doi: 10.1007/BF03189405. Eur J Drug Metab Pharmacokinet. 1979. PMID: 114397
-
Pharmacokinetics of anticancer drugs in children.Clin Pharmacokinet. 1987 Mar;12(3):168-213. doi: 10.2165/00003088-198712030-00002. Clin Pharmacokinet. 1987. PMID: 3555940 Review.
-
Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet. 1983 May-Jun;8(3):202-32. doi: 10.2165/00003088-198308030-00002. Clin Pharmacokinet. 1983. PMID: 6189661 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
